Remove 2025 Remove Insurance Coverage and Processing Remove Packaging
article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. Kennedy Jr.

article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. The approval process for cell and gene therapy candidates is tricky, however, given their high-cost and oft-debated benefit-risk ratio. Topic sponsors are not involved in the creation of editorial content.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

On the global stage, AI and Machine Learning (ML) drove drug discovery and process optimisation, especially as large-scale pharma companies adopted AI for precision medicine. Building sophisticated laboratories, recruiting scientific talent, and collaborating with global research institutions are essential steps in this process.

article thumbnail

SpliceBio secures $135m for gene therapy development

Pharmaceutical Technology

June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Stargardt disease is a genetic retinal condition, resulting in progressive loss of vision and blindness. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Give your business an edge with our leading industry insights.

article thumbnail

NHC Comments on Medicare Prescription Payment Plan

Putting Patients First Blog

The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. Similarly, updating the Explanation of Benefits to include visual aids and examples will clarify MPPP’s impact on cost-sharing and coverage.

article thumbnail

NHC Comments on Medicare Prescription Payment Plan

Putting Patients First Blog

The NHC supports the development and use of processes and tools that enhance beneficiary experience, making interactions with the MPPP smoother and more intuitive for all beneficiaries. Similarly, updating the Explanation of Benefits to include visual aids and examples will clarify MPPP’s impact on cost-sharing and coverage.

article thumbnail

Ethris and Thermo Fisher partner on mRNA solutions

Pharmaceutical Technology

June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Ethris’ platform technologies have shown favourable results in Phase I trials for ETH47. These platforms are designed for safe drug production while allowing scaleable manufacturing processes. Credit: Cryptographer/Shutterstock.